USIran Tensions Snowflake Rally Robinhood AI Key Market Moves Agnico Eagle Mines Announces 24 Billion Hope Bay Mine Redevelopment Amid Strong Earnings Momentum Tech Billionaires Sway Trump to Abandon AI Executive Order Amidst Regulatory Divisions Traders See Rising Odds of Fed Rate Hike by Mid2027 Prediction Markets Signal UK Childcare Costs Threaten Family Affordability Government Warns SP 500 and Nasdaq Reach New Record Closes as AI Optimism Drives Rally Micron Crosses 1 Trillion Market Cap HCA Q1 2026 Earnings EPS Slightly Misses Estimates Stock Edges Higher Amid Cautious Sentiment EML Q1 2026 Earnings Significant EPS Miss Despite Slight Stock Uptick Brilliant Earth Group Inc BRLT Q1 2026 Earnings EPS Misses Estimates as Stock Rises on Operational Progress FELE Q1 2026 Earnings EPS Beats Estimates by 755 Stock Rises SRFM Q1 2026 Earnings EPS Beats Estimate by 263 as Revenue Remains Undisclosed OEC Q1 2026 Earnings Shares Rally Despite Steep EPS Miss NRG Energy Sheds 17 as Shares Test Key Support Levels Aurora Innovation Inc AUR Edges Lower Amid Market Caution Key Levels in Focus LaFayette Acquisition Corp Unit LAFAU Holds Steady at 1006 Stability in a SPAC Market Genie Energy GNE Moves Above Support After Modest Gain Faces Key Resistance at 1463 YETI Holdings YETI Gains 18 as Shares Test Key Resistance Zone UK Heatwave and Travel Disruptions May Influence Holiday Spending and Transport Sector SABS Q1 2026 Earnings WiderthanExpected Loss as Biotech Continues Development Shares Edge Higher Ecopetrol EC Slips 101 as Energy Sector Headwinds Persist Key Support at 1403 in Focus ENVB Q4 2024 Earnings Deep EPS Miss Amid No Revenue Stock Rises 7 AGIG Q3 2012 Earnings Significant EPS Miss Sends Stock Lower PHI Q1 2026 Earnings EPS Slightly Misses Estimates Stock Posts Modest Gain RC Q1 2026 Earnings Deep EPS Miss Signals Heightened Stress ATAT Q1 2026 Earnings EPS Surges Past Expectations by 25 Stock Declines Despite Strong Performance Destination XL Group Q1 2026 Earnings Deep EPS Miss Sends Stock Lower C4 Therapeutics Q1 2026 Earnings EPS Surprises to the Upside as Biotech Focuses on Pipeline Execution